CureMetrix is a global leader in Artificial Intelligence for medical imaging, committed to advancing technology that improves disease detection and cancer survival rates across the globe. Its mission is to help save lives and support improved clinical and financial outcomes, delivering technology that radiologists, healthcare systems, and patients can rely on with confidence. cmTriage® is FDA-cleared for commercial use in the U.S. cmTriage® and cmAssist® are ANVISA cleared in Brazil. cmAssist®, cmAngio™, and cmDensity™ are in development and are not yet available for commercial use in the U.S.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2014
- Website
- curemetrix.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of CureMetrix?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now